LPTX
Leap Therapeutics Inc
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
leap therapeutics (nasdaq: lptx) is a clinical-stage biopharmaceutical company acquiring and developing novel therapeutics at the leading edge of cancer research. for more information about leap therapeutics, visit http://www.leaptx.com or our public filings with the sec that are available via edgar at http://www.sec.gov or via http://www.investors.leaptx.com.
Market Cap: 60.3 Million
Primary Exchange: NASDAQ
Website: https://www.leaptx.com/
Shares Outstanding: 25.6 Million
Float: 0
Dividend: 0.0 (0.0%)
Beta: 0.9670719172484228
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Ethical Flags
Longest drawdown: 1877 trading days
From: 2018-04-12 To: 2024-03-07
Lowest Point:
Leap Therapeutics to Present at the 2019 Raymond James Life Sciences and MedTech Conference
via: PR Newswire at 2019-06-11 03:00:00:000
CAMBRIDGE, Mass. , June 11, 2019 /PRNewswire/ --Leap Therapeutics, Inc. (NASDAQ: LPTX), a biotechnology company developing targeted and immuno-oncology therapeutics, today announced that Christopher K. Mirabelli , Ph.D., Chairman, President and Chief Executive Officer, will present… read more...
Leap Therapeutics to Present at the 2019 Raymond James Life Sciences and MedTech Conference
via: PR Newswire at 2019-06-11 03:00:00:000
CAMBRIDGE, Mass. , June 11, 2019 /PRNewswire/ --Leap Therapeutics, Inc. (NASDAQ: LPTX), a biotechnology company developing targeted and immuno-oncology therapeutics, today announced that Christopher K. Mirabelli , Ph.D., Chairman, President and Chief Executive Officer, will present… read more...
Leap Therapeutics to Present at the 2019 Raymond James Life Sciences and MedTech Conference
via: PR Newswire at 2019-06-11 03:00:00:000
CAMBRIDGE, Mass. , June 11, 2019 /PRNewswire/ --Leap Therapeutics, Inc. (NASDAQ: LPTX), a biotechnology company developing targeted and immuno-oncology therapeutics, today announced that Christopher K. Mirabelli , Ph.D., Chairman, President and Chief Executive Officer, will present… read more...
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|